Rtw Investments, LP

Rtw Investments, LP reported 83 holdings worth US$9.92B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Rtw Investments, LP reported 83 holdings worth US$9.92B as of Sep 30, 2026. Largest: Protagonist Therapeutics, Inc., argenx SE and CG Oncology, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
83
Value as reported
US$9.92B

The filing in full

CompanySharesValue as reported% of portfolio
Protagonist Therapeutics, Inc.5.06MUS$713M7.2%
argenx SE712KUS$682M6.9%
CG Oncology, Inc.8.51MUS$604M6.1%
iRhythm Holdings, Inc.3.12MUS$354M3.6%
Insmed Incorporated3.1MUS$353M3.6%
Tango Therapeutics, Inc.14MUS$351M3.5%
Erasca, Inc.22.4MUS$329M3.3%
Spyre Therapeutics, Inc.3.69MUS$329M3.3%
RadNet, Inc.4.63MUS$319M3.2%
Tarsus Pharmaceuticals, Inc.3.48MUS$274M2.8%
Zai Lab Ltd.10.4MUS$273M2.7%
Repligen Corporation1.39MUS$266M2.7%
Guardant Health, Inc.1.48MUS$264M2.7%
Celcuity Inc.3.3MUS$263M2.6%
Oruka Therapeutics, Inc.3.14MUS$261M2.6%
Natera, Inc.600KUS$248M2.5%
Cytokinetics, Incorporated2.86MUS$189M1.9%
Establishment Labs Holdings Inc.2.67MUS$171M1.7%
Xencor, Inc.6.83MUS$170M1.7%
Madrigal Pharmaceuticals, Inc.313KUS$158M1.6%
Immunocore Holdings plc4.87MUS$148M1.5%
Stoke Therapeutics, Inc.5.62MUS$146M1.5%
ACADIA Pharmaceuticals Inc.7.14MUS$144M1.5%
Kodiak Sciences Inc1.49MUS$141M1.4%
COMPASS Pathways Plc10.9MUS$136M1.4%
Neurocrine Biosciences, Inc.943KUS$134M1.3%
Ultragenyx Pharmaceutical Inc.8.53MUS$128M1.3%
Kailera Therapeutics, Inc.10.8MUS$123M1.2%
Belite Bio, Inc.715KUS$121M1.2%
Replimune Group, Inc.8.49MUS$112M1.1%
Immunovant, Inc.3.18MUS$107M1.1%
PTC Therapeutics, Inc.1.62MUS$105M1.1%
Viridian Therapeutics, Inc.4.91MUS$101M1.0%
Castle Biosciences, Inc.2.78MUS$98.7M0.99%
Cogent Biosciences, Inc.2.31MUS$73.9M0.75%
Structure Therapeutics, Inc.2.28MUS$71.4M0.72%
Axogen, Inc.1.66MUS$69.6M0.70%
Taysha Gene Therapies, Inc.13.6MUS$66M0.67%
Orchestra BioMed Holdings, Inc.9.56MUS$59.4M0.60%
Verastem, Inc.6.72MUS$54.1M0.55%
Danaher Corporation230KUS$51M0.51%
Hinge Health, Inc.500KUS$48.6M0.49%
Rocket Pharmaceuticals, Inc.17.7MUS$46.5M0.47%
Solid Biosciences Inc.5.91MUS$42.7M0.43%
Neurogene Inc.1.51MUS$42.1M0.42%
Cullinan Therapeutics, Inc.2.36MUS$36.3M0.37%
Aquestive Therapeutics, Inc.7.43MUS$34.4M0.35%
Candel Therapeutics, Inc.3.21MUS$33.5M0.34%
Aktis Oncology, Inc.1.59MUS$31M0.31%
Savara, Inc.5.95MUS$30.7M0.31%
Kymera Therapeutics, Inc.240KUS$26.8M0.27%
Dianthus Therapeutics, Inc.248KUS$21.8M0.22%
Beta Bionics, Inc.999KUS$19M0.19%
Larimar Therapeutics, Inc.5.82MUS$18.6M0.19%
Pyxis Oncology, Inc.6.51MUS$15.2M0.15%
Century Therapeutics, Inc.8.7MUS$14.9M0.15%
Beam Therapeutics Inc.570KUS$13.9M0.14%
Surrozen, Inc.394KUS$12.7M0.13%
Heartflow, Inc.250KUS$12.4M0.13%
Freenome, Inc.743KUS$11.7M0.12%
Latigo Biotherapeutics, Inc.700KUS$11.7M0.12%
Silence Therapeutics PLC700KUS$7.65M0.08%
Ocugen, Inc.6.67MUS$6.87M0.07%
Milestone Pharmaceuticals Inc.7.83MUS$6.78M0.07%
ADARx Pharmaceuticals, Inc.300KUS$5.98M0.06%
Crescent Biopharma, Inc.373KUS$5.44M0.05%
Allogene Therapeutics, Inc.3.25MUS$5.2M0.05%
Lumexa Imaging Holdings, Inc.500KUS$5.13M0.05%
Dyne Therapeutics, Inc.300KUS$4.83M0.05%
Regenxbio Inc.556KUS$4.18M0.04%
Kalaris Therapeutics, Inc.1.3MUS$3.76M0.04%
Abivax SA26,400US$2.61M0.03%
Medline Inc.70,000US$2.43M0.02%
Capricor Therapeutics, Inc.250KUS$2.37M0.02%
Disc Medicine, Inc.30,000US$1.96M0.02%
Evommune, Inc.208KUS$1.72M0.02%
Obsidian Therapeutics, Inc.67,706US$930K<0.01%
Lexeo Therapeutics, Inc.239KUS$808K<0.01%
Tenax Therapeutics, Inc.0US$00.00%
4D Molecular Therapeutics, Inc.0US$00.00%
AtaiBeckley Inc.0US$00.00%
Avalo Therapeutics, Inc.0US$00.00%
Definium Therapeutics, Inc.0US$00.00%
Exagen Inc.0US$00.00%
IDEAYA Biosciences, Inc.0US$00.00%
ImageneBio, Inc.0US$00.00%
Maze Therapeutics, Inc.0US$00.00%
Perceptive Capital Solutions Corp0US$00.00%

Source

Download original · View original at SEC

Related